SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Biotechnology Cancer Cures
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: cootie who wrote (10)4/11/1999 9:25:00 PM
From: Mike McFarland   of 226
 
*OT!* This thread is pretty much intended
to point to cancer-related stuff. I did check
out the most recent PR however on your pick,
and I see Well documented studies to quantitate
the effectiveness of electromagnetic fields do not
exist in the literature. That says volumes
doesn't it! And it is funny that they pointed
that out right in the press release.
I'd be careful with that one.

If you are interested in companies which
are pursuing nerve regeneration, you might
want to begin your DD with Cambridge Neuroscience,
cnsi, I am hoping we might see some clinical work
later this year, they have an agreement with Bayer
for the development of recombinant human Glial Growth
Factor 2 for a whole gaggle of neuro-degenerative
conditions, e.g. MS, muscular dystrophy etc.

So, maybe we both have something in common--gamblers
who own stocks delisted to the OTC:bb. For some reason
I saw fit to invest about twenty grand in mine, how
much have you ponied up on JRSE so far...well, none
of my business. Best of luck with your penny too!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News